Stockreport

Novartis Reports Updated Positive Data From Phase III SMA Program [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF IT) in a broad group of patients aged 2 to under 18 years with spinal muscular atrophy (SMA). OAV101 IT is an investigational, one-time gene therapy for patients with SM [Read more]